Consolidated Balance Sheet - USD ($)	Mar. 31, 2021	Dec. 31, 2020
Current Assets
Cash and cash equivalents	$ 2,129	$ 111
Total Current Assets	2,129	111
Other noncurrent assets	80,000
Total Assets	82,129	111
Current Liabilities
Account payable	165,466	165,466
Accrued liabilities	1,397,693	1,554,862
Convertible note payable, current	1,576,254	1,559,803
Derivative liabilities	2,460,803	2,298,820
Related party payables	4,505	4,505
Total current liabilities	5,604,721	5,583,456
Total Liabilities	5,604,721	5,583,456
Commitments and contingencies
Stockholders’ Deficit:
Preferred stock - Series A, $0.00001 par value. 69,999,990 shares authorized; 10,000,0000 shares issued and outstanding as of March 31, 2021 and December 31, 2020, respectively	100	100
Preferred stock - Series D, $0.00001 par value. 1 share authorized; 1 and zero shares issued and outstanding as of March 31, 2021 and December 31, 2020, respectively
Preferred stock - Series E, $0.00001 par value. 50 shares authorized; 48 and 20 shares issued and outstanding as of March 31, 2021 and December 31, 2020, respectively
Common stock, $0.001 par value. 1,000,000,000 shares authorized; 104,141,859 and 101,925,194 shares	104,142	101,925
Additional paid In Capital	9,573,541	8,984,757
Accumulated deficit	(15,200,375)	(14,670,127)
Total Stockholders' Deficit	(5,522,592)	(5,583,345)
Total Liabilities and Stockholders' Deficit	$ 82,129	$ 111